Say It Isn't So: Yale Medical Favored Black and Hispanic Applicants
On Thursday, May 14, the U.S. Department of Justice (DOJ) formally accused the Yale University School of Medicine of violating Title VI of the Civil Rights Act of 1964 by intentionally maintaining a race-based admissions program.
After a year-long investigation, the DOJ's Civil Rights Division demonstrated that Yale's leadership continued to selectively favor Black and Hispanic applicants over White and Asian ones. The federal government asserts this is a direct, willful circumvention of the Supreme Court's 2023 ruling outlawing affirmative action.
The Evidence: Disparities in Recent Class Data
The core of the DOJ’s legal argument rests heavily on stark statistical disparities discovered in the academic metrics of incoming medical school classes between 2023 and 2025. According to federal data released from the investigation, the academic profiles of admitted students in the most recent classes were highly stratified by race:
Applicant Race | Median GPA | Median MCAT Percentile |
Asian | 3.98 | 100th |
White | 3.97 | 100th |
Hispanic | 3.91 | 94th |
Black | 3.88 | 95th |
The DOJ used this applicant-level data to calculate that a Black applicant had as much as 29 times higher odds of receiving an admission interview than an equally qualified Asian applicant. Because Yale's class diversity metrics remained remarkably stable before and after the 2023 Supreme Court decision, the DOJ argues this data points to a "willful failure to comply."
Part of a Broader Crackdown
Yale is not alone in the federal crosshairs. This finding comes just a week after the DOJ leveled nearly identical discrimination accusations against UCLA’s David Geffen School of Medicine. Higher education experts report that the federal government currently has dozens of elite universities under active investigation—signaling a sweeping, coordinated campaign to dismantle race-conscious admissions nationwide.
The Nuclear Option: Risk of Losing Federal Funding
While the DOJ is currently seeking a "voluntary resolution agreement" over an immediate lawsuit, the stakes for Yale are existential. Title VI strictly prohibits institutions holding federal funds from practicing racial discrimination. If Yale refuses to alter its admissions procedures, the government's ultimate leverage is pulling the plug on funding—jeopardizing hundreds of millions in vital federal assistance, including NIH research grants.
Between the Lines: Surprise, taxpayer funding now requires following the law.